Gotham Asset Management LLC Invests $6.24 Million in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Gotham Asset Management LLC bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 157,461 shares of the company's stock, valued at approximately $6,243,000. Gotham Asset Management LLC owned 0.17% of Acadia Healthcare at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Tidal Investments LLC increased its holdings in Acadia Healthcare by 7.9% in the third quarter. Tidal Investments LLC now owns 4,664 shares of the company's stock valued at $296,000 after buying an additional 340 shares in the last quarter. Franklin Resources Inc. increased its holdings in Acadia Healthcare by 273.1% in the third quarter. Franklin Resources Inc. now owns 105,228 shares of the company's stock valued at $6,673,000 after buying an additional 77,027 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company's stock valued at $41,653,000 after buying an additional 13,368 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC traded up $0.51 on Friday, reaching $26.15. 2,120,582 shares of the company's stock were exchanged, compared to its average volume of 1,703,613. The stock has a market cap of $2.41 billion, a PE ratio of 8.57, a P/E/G ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The stock's fifty day moving average price is $26.19 and its 200-day moving average price is $35.66. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. During the same period in the previous year, the business posted $0.84 earnings per share. Sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Bank of America cut their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. Barclays cut their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday. KeyCorp cut their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday. Mizuho cut their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research note on Wednesday. Finally, Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.